Keratinocyte growth factor protects murine hepatocytes from tumor necrosis factor-induced apoptosis in vivo and in vitro

Hepatology

Volumn 27, Issue 6, 1998, Pages 1584-1591

  Senaldi, Giorgio ^a   Shaklee, Christine L ^a   Simon, Bernadett ^b   Rowan, Christopher G ^a   Lacey, David L ^a   Hartung, Thomas ^b  

^a AMGEN INC   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSAMINE; KERATINOCYTE GROWTH FACTOR; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DNA DEGRADATION; LIVER FAILURE; LIVER PROTECTION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DACTINOMYCIN; DRUG ANTAGONISM; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HUMANS; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED BALB C; PROTEIN SYNTHESIS INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031749656     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270618     Document Type: Article

References (19)

1. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A 1989;86:802-806.
2. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989;245:752-755.
3. Marchese C, Rubin J, Ron D, Faggioni A, Torrisi MR, Messina A, Frati L, et al. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: Differentiation response distinguishes KGF from EGF family. J Cell Physiol 1990;44:326-332.
4. Miki T, Fleming T, Bottaro D, Rubin J, Ron D, Aaronson S. Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science 1991;251:72-75.
5. Werner S, Peters KV, Longaker MT, Fuller-Pace F, Banda MJ, Williams LT. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci U S A 1992;89:6896-6900.
6. Pierce GF, Yanagihara D, Klopchin K, Danilenko DM, Hsu E, Kenney WC, Morris CE Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. J Exp Med 1994;179:831-840.
7. Staiano-Coico L, Krueger JG, Rubin JS, D'limi S, Vallat VP, Valentino L, Fahrey T III, et al. Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J Exp Med 1993;178:865-878.
8. Panos RS, Rubin JS, Aaronson SA, Mason RJ. Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin binding growth factors for alveolar type II cells in conditioned medium. J Clin Invest 1993;92:969-977.
9. Ulich T, Yi ES, Longmuir K, Yin S, Biltz R, Morris CF, Housley RM, et al. Keratinocyte growth factor is a growth factor for Type II pneumocytes in vivo. J Clin Invest 1994;93:1298-1306.
10. Yi ES, Yin S, Harclerode DL, Bedoya A, Bikhazi NB, Housley R, Aukerman SL, et al. Keratinocyte growth factor induces pancreatic ductal epithelial proliferation. Am J Pathol 1994;145:80-85.
11. Ulich TR, Yi ES, Cardiff R, Yin S, Bikhazi N, Morris CF, Pierce GE Keratinocyte growth factor is a growth factor for mammary epithelium in vivo: the mammary epithelium of lactating rats are resistant to the proliferative action of KGF Am J Pathol 1994;144:862-868.
12. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA, Cunha GR. Keratinocyte growth factor function in epithelial induction during seminal development. Proc Natl Acad Sci U S A 1994;91:1074-1078.
13. Housley RM, Morris CF, Boyle W, Ring B, Biltz R, Tarpley JE, Aukerman SL, et al. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 1994;94:1764-1777.
14. Bosch A, McCray PB, Chang SMW, Ulich TR, Simonet WS, Jolly DJ, Davidson BL. Proliferation induced by keratinocyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytes. J Clin Invest 1996;98:2683-2787.
15. Galanos C, Freudenberg MA, Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979;76:5939-5943.
16. Chojkier M, Fierer J. D-galactosamine hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice. Gastroenterology 1985;88:115-121.
17. Lehmann V, Freudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987;165:657-663.
18. Wendel A. Biochemical pharmacology of inflammatory liver injury in mice. Methods Enzymol 1990;186:675-680.
19. Wendel A, Tiegs G. Pharmacological intervention studies against lipopolysaccharides or TNF-α toxicity in mice. In: Fiers W, Buurman WA, eds. Tumor Necrosis Factor: Molecular and Cellular Biology and Clinical Relevance. Basel: Karger, 1993:120-125.